Laboratory Interpretation for Fatty Liver Patient
Your patient's labs show no viral hepatitis but a markedly elevated GGT (300 IU/L, 5× upper limit of normal), which strongly suggests either advanced NAFLD with significant fibrosis or an alternative cause of liver injury that requires immediate investigation.
Viral Hepatitis Screening: Negative
- Hepatitis A: Negative anti-HAV IgM rules out acute hepatitis A infection 1
- Hepatitis B: Negative HBsAg and negative anti-HBc IgM exclude both chronic and acute hepatitis B 2
- Hepatitis C: Non-reactive anti-HCV antibody excludes hepatitis C infection 1
These results confirm no viral etiology for the fatty liver.
Critical Finding: Markedly Elevated GGT
The GGT of 300 IU/L (5× upper limit) is the most concerning finding and requires urgent attention beyond simple fatty liver.
GGT Elevation in NAFLD Context
- In NAFLD patients, elevated GGT independently correlates with advanced fibrosis (stage 3-4) and more severe hepatic inflammation 3, 4
- GGT >60 IU/L in chronic liver disease patients is associated with histologic fibrosis scores ≥2 and predicts worse outcomes 4
- Your patient's GGT of 300 IU/L far exceeds this threshold, suggesting either advanced NAFLD or a concurrent process 3
Alternative Diagnoses to Consider
This degree of GGT elevation warrants investigation for:
- Alcohol use: Document detailed alcohol history using AUDIT-C questionnaire, as even undisclosed alcohol can cause this pattern 1
- Medications: Review all medications including over-the-counter and herbal supplements that may cause cholestatic injury 1
- Cholestatic liver disease: Consider primary biliary cholangitis, primary sclerosing cholangitis, or biliary obstruction despite normal INR
- Metabolic factors: High triglycerides independently predict fatty liver progression in patients with elevated GGT 5
Reassuring Findings
- Normal INR (0.9): Indicates preserved synthetic liver function, making decompensated cirrhosis unlikely 1
- Normal Vitamin B1: Rules out nutritional deficiency-related liver injury 1
Immediate Next Steps for Gastroenterology
The GI consultant must:
Complete the liver disease workup including autoimmune markers (ANA, ASMA, immunoglobulins), ceruloplasmin, alpha-1 antitrypsin, and iron studies 1
Perform fibrosis risk stratification using FIB-4 score or NAFLD fibrosis score immediately 1
Obtain detailed history for:
Assess cardiovascular and metabolic risk factors as NAFLD patients require comprehensive metabolic management 1
Common Pitfall
Do not assume this is simple fatty liver based on ultrasound alone. The 5-fold GGT elevation suggests either advanced NAFLD with significant fibrosis or a superimposed cholestatic/toxic process that requires thorough investigation before attributing everything to NAFLD 3, 4.